Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company also provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane full-power x-ray system, including c-arm, powered table, motorized boom, and large high-definition monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. Stereotaxis, Inc. markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with Osypka AG to develop a magnetic ablation catheter using Stereotaxis' robotic technology. Stereotaxis, Inc. was incorporated in 1990 and is headquartered in Saint Louis, Missouri.

Stereotaxis, Inc.

Cyber Surgery develops innovative robotic assistants for seamless spinal procedures, focusing on surgical planning and vertebral fusion.

Cyber Surgery

Vicarious Surgical develops robotic systems designed for minimally invasive surgery, focusing on abdominal access and visualization through a single port.

Vicarious Surgical

Zimmer Biomet develops and provides medical technology solutions aimed at alleviating pain and improving the quality of life for people around the world. Self-described as committed to advancing healthcare through cutting-edge technology.

Zimmer Biomet

Stereotaxis is involved in advancing robotics in interventional medicine, specifically in the field of surgical robotics.

Metric
Company Name	Stereotaxis, Inc.	Cyber Surgery	Vicarious Surgical	Zimmer Biomet
Symbol	STXS
MSH ID	COM:STEREOTAXIS	COM:CYBER-SURGERY	COM:VICARIOUSSURGICAL	EU:ZIMMERBIOMET
Market	STOCKS	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Medical - Instruments & Supplies	Medical Devices	Medical Devices	Medical Devices
Country	US	ES	US	EU
Stage		Non Equity Assistance
Employee Count	122
Website	stereotaxis.com	cyber-surgery.com	vicarioussurgical.com	zimmerbiomet.eu
LinkedIn		cyber-surgery		zimmerbiomet
Founders

Metric
Market Cap	153.72M
Enterprise Value
Monthly Web Traffic		463	24.68K
Web Traffic Growth			-0.01
Valuation
Raised Capital

Metric
Revenue	26.77M
Revenue (LTM)
Revenue (NTM)
Gross Profit	14.86M
EBITDA	-21.24M
Operating Income	-21.84M
Net Income	-20.71M
EPS	-0.26
Diluted EPS	-0.26
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.59
Operating Profit Margin	-0.77
EBITDA Margin	-0.79
Net Profit Margin	-0.75
Return on Equity	-0.80
Return on Assets
Return on Capital Employed

STXS

COM:STEREOTAXIS

Stereotaxis

1.83

+2.23%

0.04

Last Close

1.79

12/03 20:00

Market Cap

153.72M

Beta: -

Volume Today

348.63K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-9.76
P/B Ratio	7.81
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	8.45
EV Multiple	-7.61

Metric
Days Sales Outstanding	64.89
Days Payables Outstanding	90.52
Days Inventory Outstanding	350.43
Operating Cycle	393.19
Cash Conversion Cycle	236.70
Asset Turnover	0.69

Metric
Operating Cash Flow	-9.14M
Free Cash Flow	-9.51M
Cash Flow to Debt
Operating Cash Flow/Sales	-0.24
Free Cash Flow Yield	-0.05

Metric
Cash & Equivalents	20.34M
Accounts Receivable	1.27M
Inventory	8.43M
Goodwill
Debt to Capitalization	0.24
Debt to Assets	0.13
Current Ratio	2.73
Quick Ratio	1.82

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.27
R&D to Revenue	0.35
SG&A to Revenue	0.49